NHLBI at the 18th Non-Dilutive Funding Summit (2023) with Dr. Kathleen Rousche скачать в хорошем качестве

NHLBI at the 18th Non-Dilutive Funding Summit (2023) with Dr. Kathleen Rousche

NHLBI The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders. DR. ROUSCHE Dr. Kathleen Rousche serves as the Director of the Innovation and Commercialization Office within the Division of Extramural Research Activities at the National Heart Lung and Blood Institute of the National Institutes of Health. In this role, Dr. Rousche oversees activities designed to help innovators in academia and industry translate new and promising discoveries into biomedical products that prevent, diagnose, and treat heart, lung, blood, and sleep diseases and disorders. Dr. Rousche’s office coordinates and serves as a central point of contact for the NHLBI Small Business Programs (SBIR/STTR) and supports translational research initiatives directed at advancing promising technologies to the marketplace. Services offered to innovators include pre-application advice, entrepreneurial education, product and business development resources during funding periods, and access to potential federal and private sector partners that may support further technology development, to more efficiently and effectively move discoveries to benefit public health. Dr. Rousche has a diverse background in translational biomedical research, program administration, teaching, and alliance and project management. She worked in industry, academia, and medical communications prior to joining the NIH. FREEMIND Founded in 1999, the FreeMind Group helps life science companies secure non-dilutive funding to fund R&D. Every year FreeMind garners over $100 million for its clients, with awards ranging from hundred-thousand dollar grants to multi-million dollar programs. Funding sources include NIH, DOD, BARDA, NSF, FDA, etc., as well as private foundations. Learn more here: https://freemindgroup.com/about-us/. You may find our LinkedIn page useful, as we regularly post news about non-dilutive funding opportunities, announcements about conferences with the best partnering for life science professionals, and discounts for those conferences. Connect with us here:   / freemind-group  . We hope you gain lots of useful information from these recordings of the 18th Non-Dilutive Funding Summit.